Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. Dezember 2021 08:00 ET | Quelle: LiVDerm

LiVDerm to Host Leaders in Pediatric Dermatology at MOPD’s 30th Anniversary Symposium

Boca Raton, FL, Dec. 09, 2021 (GLOBE NEWSWIRE) -- LiVDerm announced dates for the 2022 Masters of Pediatric Dermatology (MOPD) symposium, marking its benchmark 30th anniversary. On February 10-11,...
08. Dezember 2021 08:03 ET | Quelle: Stereotaxis, Inc.

Stereotaxis Robotic Technology Reduces Incidence of Silent Cerebral Embolism During Atrial Fibrillation Ablation in New Peer-Reviewed Publication

ST. LOUIS, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in...
06. Dezember 2021 10:00 ET | Quelle: BioSig Technologies, Inc.

BioSig to Participate in the Benzinga All Access Event on December 14, 2021

Westport, CT, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
06. Dezember 2021 07:10 ET | Quelle: GH Research PLC

GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates

DUBLIN, Ireland, Dec. 06, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
06. Dezember 2021 07:00 ET | Quelle: GH Research PLC

GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression

Primary endpoint met in Phase 2 part of clinical trial for GH001 in TRD 7 of 8 patients (87.5%) were in remission (MADRS ≤10) at day 7 after dosing (p<0.0001) Secondary endpoints met Mean change...
01. Dezember 2021 09:25 ET | Quelle: BioSig Technologies, Inc.

BioSig Technologies, Inc. Appoints Gray Fleming as Chief Commercial Officer

Westport, CT, Dec. 01, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
29. November 2021 07:00 ET | Quelle: Iveda

Iveda Launches Next-Gen 4G Body Camera with AI Capabilities

MESA, Ariz, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Iveda (OTCQB: IVDA), the worldwide provider of IvedaAI™ intelligent video search technology, Sentir® video surveillance products, IvedaPinpoint™ and...
24. November 2021 09:00 ET | Quelle: Research Dive

Global Optical Detector Market Predicted to Generate a Revenue of $8,259.3 Million by 2028, Growing at a CAGR of 12.4% from 2021-2028 – Exclusive Report [224 Pages] By Research Dive

New York, USA, Nov. 24, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global optical detector market is expected to garner a revenue of $8,259.3 million by 2028,...
23. November 2021 09:00 ET | Quelle: Research Dive

Global Green Hydrogen Market Envisioned to Garner $9,834.3 Million in Revenue and Rise at a CAGR of 54.7% over the Estimated Timeframe from 2021-2028 – Exclusive Report [233 Pages] By Research Dive

New York, USA, Nov. 23, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global green hydrogen market is anticipated to generate a revenue of $9,834.3 million and rise...
22. November 2021 08:00 ET | Quelle: Brain Scientific Inc.

Brain Scientific and LOK Corporation Announce Global Partnership Advancing Innovative Neurodiagnostic Devices

NEW YORK, Nov. 22, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a leader in the medical technology market, today announces its partnership with LOK Corporation...

Vorherige Seite

Nächste Seite